Category: Cancer Treatment
Cancer Treatment market research reports by Icon Group International, Inc.
-
The 2025-2030 World Outlook for Endocrine Pancreatic Cancer Drugs
The 2025-2030 World Outlook for Endocrine Pancreatic Cancer Drugs This study covers the world outlook for endocrine pancreatic cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in q ... Read More
-
The 2025-2030 World Outlook for Breast Cancer Diagnostics and Drug Technologies
The 2025-2030 World Outlook for Breast Cancer Diagnostics and Drug Technologies This study covers the world outlook for breast cancer diagnostics and drug technologies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P ... Read More
-
The 2025-2030 World Outlook for Granulocyte Colony Stimulating Factor (G-CSF) Cancer Supportive Care
The 2025-2030 World Outlook for Granulocyte Colony Stimulating Factor (G-CSF) Cancer Supportive Care This study covers the world outlook for granulocyte colony stimulating factor (g-CSF) cancer supportive care across more than 190 countries. For each year reported, estimates are given for the latent ... Read More
-
The 2025-2030 World Outlook for Cancer Testing-Screening
The 2025-2030 World Outlook for Cancer Testing-Screening This study covers the world outlook for cancer testing-screening across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More
-
The 2025-2030 World Outlook for Cancer Therapeutics
The 2025-2030 World Outlook for Cancer Therapeutics This study covers the world outlook for cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2025-2030 World Outlook for Pancreatic Cancer Drugs
The 2025-2030 World Outlook for Pancreatic Cancer Drugs This study covers the world outlook for pancreatic cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More
-
The 2025-2030 World Outlook for Immunotherapy Drugs
The 2025-2030 World Outlook for Immunotherapy Drugs This study covers the world outlook for immunotherapy drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2025-2030 World Outlook for Medical Marijuana
The 2025-2030 World Outlook for Medical Marijuana This study covers the world outlook for medical marijuana across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dol ... Read More
-
The 2025-2030 World Outlook for NSCLC Therapeutics
The 2025-2030 World Outlook for NSCLC Therapeutics This study covers the world outlook for NSCLC therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. d ... Read More
-
The 2025-2030 World Outlook for Colorectal Cancer Monoclonal Antibodies (mAb)
The 2025-2030 World Outlook for Colorectal Cancer Monoclonal Antibodies (mAb) This study covers the world outlook for colorectal cancer monoclonal antibodies (mAb) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E ... Read More
-
The 2025-2030 World Outlook for Colorectal Cancers
The 2025-2030 World Outlook for Colorectal Cancers This study covers the world outlook for colorectal cancers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. d ... Read More
-
The 2025-2030 World Outlook for Targeted Therapy Liver Cancer Drugs
The 2025-2030 World Outlook for Targeted Therapy Liver Cancer Drugs This study covers the world outlook for targeted therapy liver cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country ... Read More
-
The 2025-2030 World Outlook for Non-Melanoma Skin Cancers
The 2025-2030 World Outlook for Non-Melanoma Skin Cancers This study covers the world outlook for non-melanoma skin cancers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mill ... Read More
-
The 2025-2030 World Outlook for Noninvasive Cancer Diagnostics
The 2025-2030 World Outlook for Noninvasive Cancer Diagnostics This study covers the world outlook for noninvasive cancer diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in questio ... Read More
-
The 2025-2030 World Outlook for Cancer Immunotherapies
The 2025-2030 World Outlook for Cancer Immunotherapies This study covers the world outlook for cancer immunotherapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More
-
The 2025-2030 World Outlook for Pap Smear Tests for Cervical Cancer Diagnostic Testing
The 2025-2030 World Outlook for Pap Smear Tests for Cervical Cancer Diagnostic Testing This study covers the world outlook for pap smear tests for cervical cancer diagnostic testing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential indust ... Read More
-
The 2025-2030 World Outlook for Particle Treatment Devices
The 2025-2030 World Outlook for Particle Treatment Devices This study covers the world outlook for particle treatment devices across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More
-
The 2025-2030 World Outlook for Kidney Cancer-Treating Drugs
The 2025-2030 World Outlook for Kidney Cancer-Treating Drugs This study covers the world outlook for kidney cancer-treating drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More
-
The 2025-2030 World Outlook for Lymphoma Treatments
The 2025-2030 World Outlook for Lymphoma Treatments This study covers the world outlook for lymphoma treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2025-2030 World Outlook for Malignant Melanoma Treatments
The 2025-2030 World Outlook for Malignant Melanoma Treatments This study covers the world outlook for malignant melanoma treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question ... Read More
-
The 2025-2030 World Outlook for Bile Duct Cancer (Cholangiocarcinoma) Treatments
The 2025-2030 World Outlook for Bile Duct Cancer (Cholangiocarcinoma) Treatments This study covers the world outlook for bile duct cancer (cholangiocarcinoma) treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings ... Read More
-
The 2025-2030 World Outlook for Alkylating Gynaecological Cancer Drugs
The 2025-2030 World Outlook for Alkylating Gynaecological Cancer Drugs This study covers the world outlook for alkylating gynaecological cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the co ... Read More
-
The 2025-2030 World Outlook for Urothelial Cancer Drugs
The 2025-2030 World Outlook for Urothelial Cancer Drugs This study covers the world outlook for urothelial cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More
-
The 2025-2030 World Outlook for Endometrial Cancer Treatments
The 2025-2030 World Outlook for Endometrial Cancer Treatments This study covers the world outlook for endometrial cancer treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question ... Read More
-
The 2025-2030 World Outlook for Cancer Cachexia
The 2025-2030 World Outlook for Cancer Cachexia This study covers the world outlook for cancer cachexia across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars ... Read More
Research Assistance
